Trust Worldwide’s Global Reach and Strategic Design for Your Sickle Cell Anemia Clinical Trial

Sickle cell anemia is a congenital condition characterized by a lack of healthy red blood cells. Symptoms include pain, swelling of extremities, impaired growth and vision, and vulnerability to infections. Research in the past four decades has resulted in an increased life expectancy, and ongoing research seeks to reduce the risk of more serious complications. Bone marrow and stem cell research has rendered some promising results, but more research is required. Because it is a rare condition, recruitment of sufficient qualified trial volunteers is a challenge for researchers.

When you’re studying a rare disease indication, you need a CRO with strategic precision and geographical reach. With operations covering 60+ countries, Worldwide Clinical Trials has access to hard-to-find patient populations, as well as an intimate understanding of regional regulatory conditions and standards of care. Our clinical, operational, and regulatory rigor equips us to design and execute your study to ensure optimal results that pass scrutiny, making the best strategic use of limited time and financial resources. 

For your Phase I-IV clinical trial or real-world evidence study, count on Worldwide Clinical Trials.